Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990 - PubMed (original) (raw)
Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990
J H Bower et al. Neurology. 1997 Nov.
Abstract
Information on the incidence of progressive supranuclear palsy (PSP) is limited; incidence rates for multiple system atrophy (MSA) are not available. We studied the incidence of PSP and MSA in Olmsted County, Minnesota, for the years 1976 to 1990. This study was part of a larger investigation of all forms of parkinsonism. We used the medical records-linkage system of the Rochester Epidemiology Project to identify all subjects whose records contained documentation of any from of parkinsonism, related neurodegenerative diseases, or tremor of any type. A nurse abstractor screened the records and, when applicable, a neurologist reviewed them to determine the presence or absence of parkinsonism. Cases of parkinsonism were classified using specified diagnostic criteria. Population denominators were derived from census data and were corrected by removing prevalent cases of parkinsonism. Over the 15 years of the study, we found 16 incident cases of PSP and nine incident cases of MSA. No cases of PSP or MSA had onset before age 50 years. The average annual incidence rate (new cases per 100,000 person-years) for ages 50 to 99 years was 5.3 for PSP and 3.0 for MSA. The incidence of PSP increased steeply with age from 1.7 at 50 to 59 years to 14.7 at 80 to 99 years, and was consistently higher in men. Median survival time from symptom onset was 5.3 years for PSP and 8.5 years for MSA. The incidence of PSP increases with age and is consistently higher in men at all ages. PSP and MSA are more common than previously recognized.
Similar articles
- Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990.
Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Bower JH, et al. Neurology. 1999 Apr 12;52(6):1214-20. doi: 10.1212/wnl.52.6.1214. Neurology. 1999. PMID: 10214746 - Incidence and Trends of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Population-Based Study.
Stang CD, Turcano P, Mielke MM, Josephs KA, Bower JH, Ahlskog JE, Boeve BF, Martin PR, Upadhyaya SG, Savica R. Stang CD, et al. J Parkinsons Dis. 2020;10(1):179-184. doi: 10.3233/JPD-191744. J Parkinsons Dis. 2020. PMID: 31594251 Free PMC article. - Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia.
Kanazawa M, Tada M, Onodera O, Takahashi H, Nishizawa M, Shimohata T. Kanazawa M, et al. Parkinsonism Relat Disord. 2013 Dec;19(12):1149-51. doi: 10.1016/j.parkreldis.2013.07.019. Epub 2013 Aug 3. Parkinsonism Relat Disord. 2013. PMID: 23916652 - Predictors of survival in progressive supranuclear palsy and multiple system atrophy: a systematic review and meta-analysis.
Glasmacher SA, Leigh PN, Saha RA. Glasmacher SA, et al. J Neurol Neurosurg Psychiatry. 2017 May;88(5):402-411. doi: 10.1136/jnnp-2016-314956. Epub 2017 Mar 1. J Neurol Neurosurg Psychiatry. 2017. PMID: 28250027 Review. - Coexistence of PSP and MSA: a case report and review of the literature.
Uchikado H, DelleDonne A, Uitti R, Dickson DW. Uchikado H, et al. Acta Neuropathol. 2006 Feb;111(2):186-92. doi: 10.1007/s00401-005-0022-z. Epub 2006 Feb 3. Acta Neuropathol. 2006. PMID: 16456665 Review.
Cited by
- Update on progressive supranuclear palsy.
Litvan I. Litvan I. Curr Neurol Neurosci Rep. 2004 Jul;4(4):296-302. doi: 10.1007/s11910-004-0055-z. Curr Neurol Neurosci Rep. 2004. PMID: 15217544 Review. - Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets.
Gao C, Jiang J, Tan Y, Chen S. Gao C, et al. Signal Transduct Target Ther. 2023 Sep 22;8(1):359. doi: 10.1038/s41392-023-01588-0. Signal Transduct Target Ther. 2023. PMID: 37735487 Free PMC article. Review. - Clinicopathological outcomes of prospectively followed normal elderly brain bank volunteers.
Dugger BN, Hentz JG, Adler CH, Sabbagh MN, Shill HA, Jacobson S, Caviness JN, Belden C, Driver-Dunckley E, Davis KJ, Sue LI, Beach TG. Dugger BN, et al. J Neuropathol Exp Neurol. 2014 Mar;73(3):244-52. doi: 10.1097/NEN.0000000000000046. J Neuropathol Exp Neurol. 2014. PMID: 24487796 Free PMC article. - Lipid dysfunction and pathogenesis of multiple system atrophy.
Bleasel JM, Wong JH, Halliday GM, Kim WS. Bleasel JM, et al. Acta Neuropathol Commun. 2014 Feb 7;2:15. doi: 10.1186/2051-5960-2-15. Acta Neuropathol Commun. 2014. PMID: 24502382 Free PMC article. Review. - Environmental and occupational risk factors for progressive supranuclear palsy: Case-control study.
Litvan I, Lees PS, Cunningham CR, Rai SN, Cambon AC, Standaert DG, Marras C, Juncos J, Riley D, Reich S, Hall D, Kluger B, Bordelon Y, Shprecher DR; for ENGENE-PSP. Litvan I, et al. Mov Disord. 2016 May;31(5):644-52. doi: 10.1002/mds.26512. Epub 2016 Feb 8. Mov Disord. 2016. PMID: 26854325 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous